Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

681 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.
Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G, Espigado I, Iriondo A, Jost L, Koza V, Lenhoff S, Lisukov I, Locatelli F, Marmont A, Philippe P, Pilatrino C, Quartier P, Stary J, Veys P, Vormoor J, Wahlin A, Zintl F, Bocelli-Tyndall C, Tyndall A, Gratwohl A; Autoimmune Disease Working Party of the EBMT. Passweg JR, et al. Br J Haematol. 2004 Jun;125(6):749-55. doi: 10.1111/j.1365-2141.2004.04978.x. Br J Haematol. 2004. PMID: 15180864 Free article.
Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation.
Stern M, Passweg J, Tiercy JM, Genitsch A, Meyer-Monard S, Heim D, Tichelli A, Gratwohl A, Nissen-Druey C. Stern M, et al. Among authors: passweg j. Biol Blood Marrow Transplant. 2006 Nov;12(11):1169-75. doi: 10.1016/j.bbmt.2006.07.001. Biol Blood Marrow Transplant. 2006. PMID: 17085310 Free article.
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
Buser AS, Stern M, Bucher C, Arber C, Heim D, Halter J, Meyer-Monard S, Stussi G, Lohri A, Ghielmini M, Tichelli A, Passweg JR, Gratwohl A. Buser AS, et al. Among authors: passweg jr. Bone Marrow Transplant. 2007 Mar;39(6):335-40. doi: 10.1038/sj.bmt.1705597. Bone Marrow Transplant. 2007. PMID: 17342158 Clinical Trial.
Role of primacy of birth in HLA-identical sibling transplantation.
Bucher C, Stern M, Buser A, Heim D, Paulussen M, Halter J, Tsakiris D, Droll A, Meyer-Monard S, Tichelli A, Passweg J, Gratwohl A. Bucher C, et al. Among authors: passweg j. Blood. 2007 Jul 1;110(1):468-9. doi: 10.1182/blood-2007-02-076257. Blood. 2007. PMID: 17579188 Free article. No abstract available.
Patient and product factors affecting platelet transfusion results.
Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C, Meyer-Monard S, Halter J, Tichelli A, Gratwohl A. Heim D, et al. Among authors: passweg j. Transfusion. 2008 Apr;48(4):681-7. doi: 10.1111/j.1537-2995.2007.01613.x. Epub 2008 Jan 15. Transfusion. 2008. PMID: 18208413
Aplastic anemia and concomitant autoimmune diseases.
Stalder MP, Rovó A, Halter J, Heim D, Silzle T, Passweg J, Rischewski J, Stern M, Arber C, Buser A, Meyer-Monard S, Tichelli A, Gratwohl A. Stalder MP, et al. Among authors: passweg j. Ann Hematol. 2009 Jul;88(7):659-65. doi: 10.1007/s00277-008-0671-9. Epub 2009 Jan 13. Ann Hematol. 2009. PMID: 19139895
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality.
Cantoni N, Weisser M, Buser A, Arber C, Stern M, Heim D, Halter J, Christen S, Tsakiris DA, Droll A, Frei R, Widmer AF, Flückiger U, Passweg J, Tichelli A, Gratwohl A. Cantoni N, et al. Among authors: passweg j. Eur J Haematol. 2009 Aug;83(2):130-8. doi: 10.1111/j.1600-0609.2009.01249.x. Epub 2009 Mar 5. Eur J Haematol. 2009. PMID: 19284419
681 results